Proqr Therapeutics
(PRQR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,173 | -49,366 | -37,903 | -23,954 | -11,166 |
| Depreciation Amortization | 295 | 1,204 | 949 | 594 | 286 |
| Other Working Capital | -1,151 | 185 | -634 | -1,505 | -99 |
| Other Operating Activity | 2,093 | 8,472 | 6,753 | 4,376 | 1,620 |
| Operating Cash Flow | $-11,936 | $-39,505 | $-30,835 | $-20,489 | $-9,360 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -137 | -131 | -102 | -48 |
| Investing Cash Flow | $-5 | $-137 | $-131 | $-102 | $-48 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 370 | 1,075 | 413 | 111 | N/A |
| Common Stock Issued | N/A | 29,036 | 10,299 | 3,546 | 2,293 |
| Financing Cash Flow | $370 | $30,111 | $10,712 | $3,657 | $2,293 |
| Exchange Rate Effect | -842 | -3,017 | -2,615 | -1,631 | -440 |
| Beginning Cash Position | 59,123 | 66,914 | 69,578 | 65,114 | 63,089 |
| End Cash Position | 46,711 | 54,366 | 46,709 | 46,549 | 55,535 |
| Net Cash Flow | $-12,413 | $-12,548 | $-22,869 | $-18,565 | $-7,555 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,936 | -39,505 | -30,835 | -20,489 | -9,360 |
| Capital Expenditure | -5 | -137 | -131 | -102 | -48 |
| Free Cash Flow | -11,940 | -39,642 | -30,966 | -20,591 | -9,408 |